Xiuge Gao
Nanjing, 210095, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Triple-layered nanogel for targeted and sustained delivery of florfenicol against bacterial enteritis.
Journal: International journal of pharmaceutics: X
Published: June 15, 2026
Taste-masked tilmicosin-loaded nanostructured lipid carriers at pilot scale for improved bioavailability and enhanced efficacy against Salmonella infection in swine.
Journal: International journal of pharmaceutics: X
Published: March 21, 2026
Enhanced bioavailability of albendazole sulfoxide via binary solid dispersion: Preparation, characterization and goat pharmacokinetics.
Journal: Journal of pharmaceutical sciences
Published: January 05, 2026
Targeting ferroptosis in cancer: from mechanistic insights to therapeutic approaches.
Journal: Molecular biomedicine
Published: July 11, 2025
TFEB orchestrates ferritinophagy and ferroptosis in ionophore drug-induced hepatotoxicity: unveiling a novel therapeutic avenue.
Journal: Free radical biology & medicine
Published: March 19, 2025
Cytoskeleton disruption and plasma membrane damage determine methuosis of normal and malignant cells.
Journal: Cell & bioscience
Published: February 27, 2025
Enrofloxacin‑silver composite nano-emulsion as a scalable synergetic antibacterial platform for accelerating infected wound healing.
Journal: International journal of pharmaceutics: X
Published: December 13, 2024
New uses of halofuginone to treat cancer.
Journal: Journal of pharmaceutical analysis
Published: May 23, 2024
Florfenicol core-shell composite nanogels as oral administration for efficient treatment of bacterial enteritis.
Journal: International journal of pharmaceutics
Published: May 07, 2024
Enhanced In Vitro Antiviral Activity of Ivermectin-Loaded Nanostructured Lipid Carriers against Porcine Epidemic Diarrhea Virus via Improved Intracellular Delivery.
Journal: Pharmaceutics
Published: March 28, 2024
Injectable nano-in situ-thermosensitive-hydrogels based on halofuginone and silver for postoperative treatment against triple-negative breast cancer.
Journal: International journal of pharmaceutics
Published: March 24, 2024
Last Updated: 09/26/2026